The National Collaborative HIV/AIDS Awareness Project (NCHAAP) is part of the Indian Health Service’s (IHS) implementation plan to meet the three goals of the National HIV/AIDS Strategy in Indian Country for federally-recognized Tribes and Tribal organizations in the interest of improving Indian health care.
The goal of NCHAPP is to increase the capacity of Native communities to address HIV and AIDS. This will be achieved by creating strategic opportunities for Tribes and Tribal entities to access technical assistance and community-based prevention materials. Educational materials will be developed through comprehensive community input, all under the guidance and advice of the IHS HIV/AIDS Program, to focus on identified high risk populations.
The National Native American AIDS Prevention Center (NNAAPC) is the only national, HIV-specific, Native organization in the United States. Founded in 1987, NNAAPC is recognized as the leading resource for HIV information in Indian Country by community members, federal funders, and other national Native organizations. NNAAPC has earned this reputation through high quality and culturally appropriate training, technical assistance, materials development, advocacy, and continuity of service.
As such, NNAAPC was selected by NIHB, as a subcontractor, to operate the National Collaborative HIV/AIDS Awareness Project. NNAAPC and NIHB have a long history of collaboration which is evidenced by an MOU that honors the expertise of NIHB in working for the health of tribal and reservation-based communities and the experience of NNAAPC in advancing the state of HIV/AIDS prevention amongst all Native peoples.
For more information about the Indian Health Service HIV/AIDS Program, please visit:
For more information about the National Native American AIDS Prevention Center, please visit:
Fact Sheets on HIV/AIDS:
This clinical report provides guidance for the pediatrician in addressing the psychosocial needs of adolescents and young adults living with HIV, which can improve linkage to care and adherence to life-saving antiretroviral (ARV) therapy. Recent national case surveillance data for youth (defined here as adolescents and young adults 13 to 24 years of age) revealed that the burden of HIV/AIDS fell most heavily and disproportionately on African American youth, particularly males having sex with males. To effectively increase linkage to care and sustain adherence to therapy, interventions should address the immediate drivers of ARV compliance and also address factors that provide broader social and structural support for HIV-infected adolescents and young adults. Interventions should address psychosocial development, including lack of future orientation, inadequate educational attainment and limited health literacy, failure to focus on the long-term consequences of near-term risk behaviors, and coping ability. Associated challenges are closely linked to the structural environment. Individual case management is essential to linkage to and retention in care, ARV adherence, and management of associated comorbidities. Integrating these skills into pediatric and adolescent HIV practice in a medical home setting is critical, given the alarming increase in new HIV infections in youth in the United States.
The number of American Indians and Alaska Natives that tested positive for the Human Immunodeficiency Virus (HIV) rose by 8.7% between 2007 and 2011. This was the largest percent increase among any race/ethnicity. Tribes have responded to this growing concern by stepping up both prevention and testing efforts. More and more Native clinics are adopting routine HIV testing as a standard clinical practice. However, in order to align this practice with community demand and need, it will be important for clinical and administrative staff to understand the technology and testing options that are available. HIV tests have come a long way – from waiting two weeks for test results twenty years ago to twenty minutes and now waiting just one minute...
New treatments for Hepatitis C (HCV) are on the horizon, and this raises questions about how new medicines affect those people living with HIV and actively taking HIV medications. A new study on the efficacy of sofosbuvir in combination with interferon and ribavirin as a means to treat HCV in people co-infected with HIV has recently released promising results*. The hope was to discover a new HCV medicine that has very few to no interactions with HIV anti-retroviral medications. The results of the study were shared during the IDWeek Conference in October, 2013 and showed that overall 91% of study participants (n=23) achieved a sustained virologic response within 12 weeks with very few adverse events among the participants, and little drug-drug interactions.
*Rodriguez-Torres, M., Rodriguez-Orengo, J., Gaggar, A., et al. (October 2-6, 2013). Sofosbuvir and peginterferon alfa-2a/ribavirin for treatment-naïve genotype 1-4 HCV-infected patients who are coinfected with HIV. IDWeek 2013; San Francisco, CA. Abstract 714
To help stop the spread of HIV and sexually transmitted diseases (STDs), the Indian Health Service (IHS) supported the development of a Tribal HIV/STD Training Kit and Policy Guide. The training kit gives tribes and tribal organizations information on how to work with tribal council members, school boards, health directors, and other partnering programs on ways to prevent the transmission of HIV and STDs.
The training kit contains facts about sexual health, tools for assessing community readiness to implement a sexual health program, information to guide policy development, case studies of effective models for change, and additional resources to strengthen community sexual health activities and policies.
The kit also provides recommendations to American Indians and Alaska Natives on healthy lifestyle choices. Tribal health advocates can use the kit to guide discussions with tribal leaders and develop ideas for effective disease prevention strategies. The training kit can be downloaded from the IHS website at http://www.ihs.gov/hivaids/.
The training kit is a collaborative effort with the U.S. Department of Health and Human Services’ Office of Minority Health Resource Center and the Northwest Portland Area Indian Health Board. It is being released in conjunction with the International AIDS Conference being held in Washington, D.C., the week of July 22.
In the latest post from the series "Notes on Health Insurance and Reform," Jen Kates, Vice President and Director of Global Health & HIV Policy at the Kaiser Family Foundation, examines different insurance pathways for people with HIV and how the Affordable Care Act (ACA) is expanding coverage options for this population. The post includes a series of infographics depicting these eligibility pathways prior to the ACA, after the ACA was enacted but before 2014, and as of 2014 and beyond.